TERIFLUNOMIDE AS IMMUNOTHERAPY FOR CELIAC DISEASE – RESULTS FROM A DOUBLE-BLINDED, RANDOMIZED PHASE 2A STUDY

Louise F. Risnes  ¹     Margit Brottveit  ²     Ida Robertsen  ²     Lars Aabakken  ³     Siv Furholm  ⁴     Siv Isaksen  ⁵     Marie Johannesen  ⁵     Stine Rosenqvist Lund  ⁶     Jostein Ibsen  ⁶     Anders Åsberg  ⁶     Ludvig M. Sollid  ⁷     Knut E.A. Lundin  ^8    
1 University of Oslo, Oslo, Norway
² Oslo University Hospital Ullevål, Oslo, Norway
³ Rikshospitalet-Radiumhospitalet HF, Oslo, Norway
⁴ UIO/OUS Inst. of Health and Society, Oslo, Norway
⁵ Oslo Universitetssykehus HF, Oslo, Norway
⁶ Oslo University Hospital, Oslo, Norway
⁷ University of Oslo Inst. of Immunology Centre for Immune Regulation, Oslo, Norway
⁸ K. G. Jebsen Coeliac Disease Research Centre, University of Oslo and Oslo University Hospital, Oslo, Norway

Topic
Hepatobiliary, IBD, Small Intestine & Nutrition

Session
Big steps for coeliac and short bowel

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)